Executive Summary
Medela and M.E.A.C. Engineering have settled their dispute over U.S. Patent 8,858,534 and jointly moved to terminate the pending inter partes review. The Board has not yet instituted the IPR, and the parties seek confidentiality for the settlement agreement.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Medela LLC et al. vs M.E.A.C. Engineering Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
HL Klemove CorporationvsForas Technologies Limited
HL Klemove and Foras Technologies have jointly moved to terminate the IPR over U.S. Patent 7,502,958, citing settlement and the lack of any merits decision. The Board is expected to grant the motion under 35 U.S.C. §317(a).
Dr. Falk Pharma GMBHvsEllodi Pharmaceuticals LP
Dr. Falk Pharma has filed an IPR petition seeking cancellation of all 16 claims of Ellodi's 11,246,828 patent covering budesonide orally dispersing tablets, arguing obviousness over Dohil, Grother and FDA guidance.
Google LLC et al.vsCerence Operating Company et al.
An email from the PTAB Director notifies Google and Cerence that Director Review requests have been filed for IPR2024‑01464 and IPR2024‑01465, outlining a five‑page, five‑business‑day response limit and prohibiting new evidence.
Apple Inc.vsHBCU Messaging US LP
The Director denied Apple Inc.'s request for review of the PTAB's denial of institution in three IPRs against HBCU Messaging, leaving the institution decisions unchanged.
3Shape A/S et al.vsMedit Corporation et al.
3Shape and Medit have entered a settlement, and 3Shape filed a joint request to keep the agreement confidential under patent law provisions. The motion seeks to limit disclosure to federal agencies or parties with good cause.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.